Induction of graft-versus-host disease after autologous bone marrow transplantation.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  The Lancet

• Publication date

  1989-04-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(89)92575-0PMID 2564566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice

  1988cited by this paper
• Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.

  1988cited by this paper
• IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses.

  1988cited by this paper
• Effects of cyclosporine A on T cell development and clonal deletion.

  1988cited by this paper
• T CELL DEPLETION WITH CAMPATH‐1 IN ALLOGENEIC BONE MARROW TRANSPLANTATION

  1988cited by this paper
• Acute Graft-vs-Host Disease: Development Following Autologous and Syngeneic Bone Marrow Transplantation

  1987cited by this paper
• Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.

  1987cited by this paper
• High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

  1987cited by this paper
• Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease.

  1987cited by this paper
• Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation.

  1987cited by this paper
• Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.

  1986cited by this paper
• Immunologic classification of leukemia and lymphoma.

  1986cited by this paper
• Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

  1986cited by this paper
• Development of graft-vs.-host disease-like syndrome in cyclosporine- treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity

  1985cited by this paper
• How does bone-marrow transplantation cure leukaemia?

  1984cited by this paper
• Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin.

  1983cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper
• The skin biopsy in the diagnosis of acute graft-versus-host disease in man.

  1977cited by this paper
• Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors.

  1974cited by this paper

• Graft-Versus-Host Disease

  2019cites this paper
• Chemokine analysis as a novel diagnostic modality in the early prediction of the outcome of non-union therapy: a matched pair analysis

  2018cites this paper
• Isolated Gastrointestinal Graft versus Host Disease in a Patient of Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplantation

  2017cites this paper
• Late recurrence of autologous GvHD in a myeloma patient: a myth or diagnostic challenge?

  2017cites this paper
• Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach.

  2015cites this paper
• Is Disaccharidase Deficiency in Pediatric Patients with Graft-Versus-Host Disease ( Gvhd ) a Contributing Cause for Diarrhea ?

  2015cites this paper
• Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

  2014cites this paper
• development of autologous GVHD may be critical mediators for the γ (GVHD): interleukin 10 and interferon Cytokine and chemokine profiles in autologous graft-versus-host disease

  2013cites this paper
• Identification of fibronectin as a major factor in human serum to recruit subchondral mesenchymal progenitor cells.

  2013cites this paper
• Skin Graft-versus-host Disease Following Autologous Stem Cell Transplantation for Multiple Myeloma

  2013cites this paper
• Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia

  2012cites this paper
• Choosing a Regimen for Prophylaxis of Graft-versus-Host Disease

  2012cites this paper
• Cyclosporin

  2012cites this paper
• Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant

  2012cites this paper
• Management of autoimmune diseases after haematopoietic stem cell transplantation

  2012cites this paper
• Rescued Tolerant CD8 T Cells Are Preprogrammed to Reestablish the Tolerant State

  2012cites this paper
• Graft‐Versus‐Host Disease

  2011cites this paper
• New Approaches to the Treatment of Leukemia

  2011cites this paper
• murine model using ultraviolet-B light Studies of allogeneic bone marrow and spleen cell transplantation in a

  2011cites this paper
• response in the development of autologous GVHD disease (GVHD): evidence for the involvement of antigen-driven T-cell Characterization of the T-cell repertoire in autologous graft-versus-host

  2011cites this paper
• Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts.

  2011cites this paper
• Reconstitution of self-tolerance after hematopoietic stem cell transplantation

  2010cites this paper
• Recurrent spontaneous gastrointestinal graft-versus-host disease in autologous hematopoietic stem cell transplantation.

  2010cites this paper
• Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma

  2009cites this paper
• Rapid Immune Recovery and Graft-versus-Host Disease–like Engraftment Syndrome following Adoptive Transfer of Costimulated Autologous T Cells

  2009cites this paper
• Reviews in Medicine Haematology

  2008cites this paper
• Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance

  2008cites this paper
• Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-γ after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer

  2007cites this paper
• Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.

  2007influential citation
• Modulation of graft-versus-host disease: role of regulatory T lymphocytes.

  2006cites this paper
• A case of hepatic graft-versus-host disease complicating autologous stem cell transplantation for relapsed Hodgkin's disease

  2006cites this paper
• Morphologie und Funktion des spezifischen Immunsystems

  2006cites this paper
• Severe intestinal graft-versus-host disease following autologous stem cell transplantation

  2006cites this paper
• Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.

  2006cites this paper
• astrointestinal Graft-versus-Host Disease in ecipients of Autologous Hematopoietic Stem Cells: ncidence, Risk Factors, and Outcome

  2006cites this paper
• A Multicenter Randomized Clinical Trial Evaluating Interleukin-2 Activated Hematopoietic Stem Cell Transplantation and Post-transplant IL-2 for High Risk Breast Cancer Patients

  2005cites this paper
• Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer

  2005cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2005cites this paper
• Drug-induced lupus.

  2005cites this paper
• Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host disease.

  2005cites this paper
• Cyclosporine A, Alpha-Interferon and Interleukin-2 Following Chemotherapy with BCNU, DTIC, Cisplatin, and Tamoxifen: A Phase II Study in Advanced Melanoma

  2005cites this paper
• Autologous graft-versus-host disease: immunotherapy of breast cancer after bone marrow transplantation

  2004cites this paper
• Second autologous transplant with cyclosporin/interferon α-induced graft versus host disease for patients who have failed first-line consolidation

  2004cites this paper
• Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.

  2004cites this paper
• Autoimmune thrombocytopenia following tandem autologous peripheral blood stem cell transplantation for refractory germ cell tumor

  2004cites this paper
• Long‐term disease‐free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation

  2004cites this paper
• CD4+ T Cells Prevent Skin Autoimmunity During Chronic Autologous Graft‐Versus‐Host‐Disease

  2004cites this paper
• Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission.

  2003cites this paper
• Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.

  2003cites this paper
• Interleukin-2 Treatment of Acute Leukemia

  2003cites this paper
• Autoimmune thrombocytopenic purpura after autologous stem cell transplantation

  2003cites this paper
• Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34+ cells

  2003cites this paper
• Syngeneic graft-versus-host disease: a report of two cases and literature review

  2003cites this paper
• Autologous peripheral blood stem cell transplantation with induction of autologous graft-versus-host disease in acute myeloid leukemia

  2003cites this paper
• Role of Immunotherapy in Stem Cell Transplantation

  2003cites this paper
• Cyclosporin A-Induced Autoimmunity in the Rat: Central versus Peripheral Tolerance

  2002cites this paper
• Autoimmune and pregnancy complications in the daughter of a kidney transplant patient.

  2002cites this paper
• Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD.

  2002cites this paper
• Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival.

  2001cites this paper
• A systematic overview of chemotherapy effects in acute myeloid leukaemia.

  2001cites this paper
• Dose Intensity for Breast Cancer: Where Do We Go from Here?

  2001cites this paper
• Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC)

  2001cites this paper
• Induction of syngeneic graft‐versus‐host disease in LPS hyporesponsive C3H/HeJ mice

  2001cites this paper
• Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.

  2001cites this paper
• Autologous stem cell transplantation for acute lymphocytic leukemia in adults.

  2001cites this paper
• Bone Marrow Transplantation for Cancer and Autoimmunity

  2000cites this paper
• Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation.

  2000cites this paper
• Diagnosis of gastrointestinal graft- versus -host disease

  2000cites this paper
• Stem Cell Transplantation for Hodgkin’s Disease

  2000cites this paper
• High-Dose Therapy for Primary and Metastatic Breast Cancer

  2000cites this paper
• Induction of autologous graft-versus-host disease with cyclosporin A after peripheral blood stem cell transplantation: analysis of factors affecting induction.

  2000cites this paper
• Clinical course and predictive factors for cyclosporin‐induced autologous graft‐versus‐host disease after autologous haematopoietic stem cell transplantation

  2000cites this paper
• New approaches to treating malignances with stem cell transplantation.

  2000cites this paper
• Dermatologic changes associated with roquinimex immunotherapy after autologous bone marrow transplant.

  2000cites this paper
• Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy

  2000cites this paper
• Diagnosis of gastrointestinal graft-versus-host disease

  2000cites this paper
• Autologous bone marrow transplantation for patients with acute myeloid leukaemia: prospective follow-up study.

  2000cites this paper
• Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells

  2000cites this paper
• Autologous graft-versus-host disease.

  2000cites this paper
• Paraneoplastic Autoimmune Reactions

  1999cites this paper
• Rejection of an MHC class II negative tumor following induction of murine syngeneic graft-versus-host disease

  1999cites this paper
• Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.

  1999cites this paper
• Immunotherapy with interleukin-2 and α-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer

  1999cites this paper
• Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial

  1999cites this paper
• Cyclosporine-induced autologous graft-versus-host disease in patients with acute myeloid leukemia undergoing non-myeloablative chemotherapy without progenitor cell reinfusion

  1999cites this paper
• Graft versus host disease in autologous stem cell transplantation.

  1999cites this paper
• Bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia.

  1999cites this paper
• Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine models.

  1999cites this paper
• Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation.

  1999cites this paper
• T cell‐based immunotherapy for cancer: A virtual reality?

  1999cites this paper
• Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex

  1999cites this paper
• Graft-Versus-Host Disease the Development of Murine Syngeneic Th 1 Cytokines and NK Cells Participate in

  1999cites this paper
• Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.

  1998cites this paper
• Bone marrow transplantation for chronic lymphocytic leukemia.

  1998cites this paper
• Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood

  1998cites this paper
• Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation.

  1998cites this paper
• Cyclosporin A-induced autoimmunity: the result of defective de novo T-cell development.

  1998cites this paper
• Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation.

  1998cites this paper
• Pathogenesis of cyclosporin A-induced autoimmunity: absence of T-cell reactivity towards syngeneic antigen presenting cells.

  1998cites this paper
• A dominant role for non‐MHC gene effects in susceptibility to cyclosporin A (CsA)‐induced autoimmunity

  1998cites this paper